GLP-1, short for glucagon-like peptide-1, is a hormone that contributes to regulating appetite and blood sugar
Patients relying on compounded semaglutide should anticipate the possibility of losing access if the shortage designation is removed
But regardless of the part of the body being affected, inflammation is at the core of most symptoms of histamine intolerance
Regeneron is evaluating trevogrumab in combination with semaglutide, with and without garetosmab (an anti-activin A antibody), to determine whether layering multiple anti-muscle-loss mechanisms can improve body composition during GLP-1-mediated weight loss
Tirzepatide Dual GIP/GLP-1 agonist for weight management, glucose, and insulin regulation
Some may experience mild reductions in appetite, while others may feel more dramatic shifts in their hunger patterns